| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/05/1993 | CN1020473C Dna clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 05/05/1993 | CN1020472C Mammalian interleukin-4 |
| 05/05/1993 | CN1020458C Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols |
| 05/05/1993 | CN1020396C Process for selectirely extracting of metallo-proteins from lactoserum by adsorption and elution |
| 05/04/1993 | US5208320 Cyclic Adenylate Monophosphate |
| 05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
| 05/04/1993 | US5208230 Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
| 05/04/1993 | US5208220 Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase |
| 05/04/1993 | US5208219 Method for inducing bone growth |
| 05/04/1993 | US5208218 T cell growth factor glycoproteins |
| 05/04/1993 | US5208217 Hepatospecific insulin analogues |
| 05/04/1993 | US5208149 Regulating gene expression |
| 05/04/1993 | US5208144 Genetic engineering and hybridization |
| 05/04/1993 | US5208041 Essentially pure human parathyroid hormone |
| 05/04/1993 | US5208039 Nutrient compositions deprived of methionine and supplemented with homocysteine |
| 05/04/1993 | US5208021 Method of preparing diphtheria immunotoxins |
| 05/04/1993 | US5208019 Cardiovascular disorders |
| 05/04/1993 | US5208018 Treatment of cachexia with interleukin 2 |
| 05/04/1993 | CA1317412C Urotensin peptides |
| 05/04/1993 | CA1317288C Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 05/04/1993 | CA1317222C Increasing endogenous growth hormone |
| 05/01/1993 | CA2054608A1 Fusion proteins comprising gm-csf and il-3 |
| 04/29/1993 | WO1993008469A1 Recombinant calcium channel polypeptides |
| 04/29/1993 | WO1993008304A1 Inhibition of cytokine activity |
| 04/29/1993 | WO1993008303A1 Gene identification |
| 04/29/1993 | WO1993008288A1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 04/29/1993 | WO1993008285A1 Dimorphism genes in fungi |
| 04/29/1993 | WO1993008281A1 cDNA CLONE OF A RAT SEROTONIN TRANSPORTER AND PROTEIN ENCODED THEREBY |
| 04/29/1993 | WO1993008280A1 Recombitope peptides |
| 04/29/1993 | WO1993008279A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 04/29/1993 | WO1993008274A1 Use of thiol redox proteins for reducing disulfide bonds |
| 04/29/1993 | WO1993008273A1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 04/29/1993 | WO1993008267A1 Cell cycle controlling compositions and methods of using same |
| 04/29/1993 | WO1993008259A2 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 04/29/1993 | WO1993008216A1 Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv |
| 04/29/1993 | WO1993008215A1 Secreted mac-2-binding glycoprotein |
| 04/29/1993 | WO1993008212A1 Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| 04/29/1993 | WO1993008211A1 Tripeptide derivative anti-inflammatory agents |
| 04/29/1993 | WO1993008210A1 Vascular permeability factor targeted compounds |
| 04/29/1993 | WO1993008209A1 Diagnosis and treatment of bacterial dysentery |
| 04/29/1993 | WO1993008207A1 Novel cytokine |
| 04/29/1993 | WO1993007906A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | WO1993007900A1 In vitro antibody perfusion of kidney grafts |
| 04/29/1993 | WO1993007899A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 04/29/1993 | WO1993007895A1 Tripanosoma cruzi heparin-binding protein |
| 04/29/1993 | WO1993007893A1 Fibrinolysis and fibrinogenolysis treatment with plasmin |
| 04/29/1993 | WO1993007891A1 Epidermal growth factor therapy for non-gastroduodenal lesions |
| 04/29/1993 | WO1993007890A1 Treatment of haemophilia |
| 04/29/1993 | WO1993007889A1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 04/29/1993 | WO1993007888A1 Inhib, a factor which inhibits cytokine-activated leukocytes |
| 04/29/1993 | WO1993007887A1 Combined cellular and immunosuppressive therapies |
| 04/29/1993 | WO1993007886A1 Pharmaceutical composition containing certain peptidomimetic compounds |
| 04/29/1993 | WO1993007872A1 Lysosomal enzyme inhibitors for the treatment of neurodegenerative diseases |
| 04/29/1993 | WO1993007866A2 Compositions and methods for therapy and prevention of cancer, aids, and anemia |
| 04/29/1993 | WO1993007863A1 Methods and compositions for treating allergic reactions |
| 04/29/1993 | WO1993007861A1 Preparation and uses of multi-phase microspheres |
| 04/29/1993 | WO1993007840A1 Enzyme-orthokeratology |
| 04/29/1993 | WO1993007833A1 Biocompatible implant for the timing of ovulation in mares |
| 04/29/1993 | WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy |
| 04/29/1993 | WO1993000427A3 Neurite growth regulatory factors |
| 04/29/1993 | DE4238159A1 Treatment of prim. chronic polyarthritis and diabetes mellitus - comprises administration of gamma-interferon |
| 04/29/1993 | DE4134814A1 Neues thrombininhibitorisches protein aus zecken Tick novel thrombin protein from |
| 04/29/1993 | CA2121807A1 Method and apparatus for controlling liquid level in a knot drainer |
| 04/29/1993 | CA2121487A1 Combined cellular and immunosuppresive therapies |
| 04/29/1993 | CA2121235A1 In vitro antibody perfusion of kidney grafts |
| 04/29/1993 | CA2121137A1 Use of thiol redox proteins for reducing disulfide bonds |
| 04/29/1993 | CA2121127A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | CA2120911A1 Medicaments |
| 04/28/1993 | EP0539319A2 Pharmaceutical cyclosporin composition |
| 04/28/1993 | EP0539167A2 Peg imidates and protein derivatives thereof |
| 04/28/1993 | EP0539140A1 Lyophilized acidic fibroblast growth factor |
| 04/28/1993 | EP0539088A1 Echinocandin b derivative |
| 04/28/1993 | EP0539087A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/28/1993 | EP0538952A1 Antitumor Vaccines Comprising IL-6 Transfected Cells |
| 04/28/1993 | EP0538942A2 Peptides representing permutations of the mastoparan sequence |
| 04/28/1993 | EP0538810A2 Pharmaceutical compositions comprising IL-6 |
| 04/28/1993 | EP0538754A2 Use of antibody-containing preparations for immunosuppression |
| 04/28/1993 | EP0538463A1 Novel biologically active peptide compositions and uses therefor |
| 04/28/1993 | EP0538459A1 Phospholipid-targeted thrombolytic agents |
| 04/28/1993 | EP0538443A1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders. |
| 04/28/1993 | EP0538404A1 Fibroblast growth factor receptors |
| 04/28/1993 | EP0538401A1 Novel receptor-type phosphotyrosine phosphatase |
| 04/28/1993 | EP0538399A1 Cyclic cell adhesion modulation compounds |
| 04/28/1993 | EP0538398A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 04/28/1993 | EP0538396A1 Inhibitors of retroviral proteases |
| 04/28/1993 | EP0538395A1 Nucleic acid sequences encoding a human dopamine d 1? receptor |
| 04/28/1993 | EP0538392A1 3-phenyl-5,6-dihydrobenz c]acridine-7-carboxylic acids and related compounds as immunosuppresive agents |
| 04/28/1993 | EP0538383A1 Inhibitors of aspartic proteases |
| 04/28/1993 | EP0538374A1 Aspartic protease inhibitors |
| 04/28/1993 | EP0538367A1 Derivatives of pituitary posterior lobe hormones |
| 04/28/1993 | EP0538366A1 Retroviral protease inhibitors |
| 04/28/1993 | EP0538342A1 Igf-1 and related compounds in pregnancy |
| 04/28/1993 | EP0538318A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 04/28/1993 | EP0538300A1 O-glycosylated ifn-alpha. |
| 04/28/1993 | EP0538273A1 Alveolar surfactant proteins |
| 04/28/1993 | EP0538268A1 Targeted protection from cytotoxins |
| 04/28/1993 | EP0538267A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME |
| 04/28/1993 | EP0538266A1 PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS |
| 04/28/1993 | EP0499625A4 Conglutinin fragments, their production and use |
| 04/28/1993 | EP0485530A4 Tgf--g(b) protein compositions for inhibition of cell proliferation |